Bayer expands prothioconazole capacity
Bayer CropScience is to expand its production capacity for the fungicide, prothioconazole, over the next two years. It is to invest €30 million ($39.7 million at the current rate) in the venture at its facility in Dormagen, Germany. The expansion comes due to growing demand for fungicides, Bayer says. Prothioconazole was Bayer’s third-highest selling active ingredient last year, following a 41% rise in sales to €246 million ($325.5 million – Agrow No 563, pp 5-7). It is approved in more than 40 countries for use on cereals, canola, soybeans, pulses and peanuts against a broad spectrum of diseases. The fungicide was granted its first registration in Germany in 2004 as Proline ( Agrow No 453, p 21).